U.S. FDA 510(k) clearance for the Philips BlueControl wearable light therapy device to treat mild psoriasis

AMSTERDAM, 17-Jul-2017 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Philips BlueControl wearable light therapy … Read the full press release →